[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"heart-dysfunction-postoperative-cardiac-surgery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:heart-dysfunction-postoperative-cardiac-surgery":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100321789","goal-directed-therapy-aiming-to-optimise-oxygen-central-venous-saturation-in-children-undergoing-cardiac-surgery-100321789",false,"NCT03469440","Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery","Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery: a Randomized and Prospective Clinical Trial","Inclusion Criteria:\n\n* Elective cardiac surgery with cardiopulmonary bypass\n* Written informed consent\n\nExclusion Criteria:\n\n* Cardiac arrhythmia\n* Emergency operation\n* Hemodynamic instabillty (norepinephrine higher than 1 mcg\u002Fkg\u002Fmin)\n* Neoplasia\n* Heart transplant\n* Participation in another study","ALL","14 Years",{"count":19,"type":20},65,"ESTIMATED","INTERVENTIONAL",[23],"NA","The purpose of this study is evaluate goal-directed therapy with continuous central venous saturation compared to standard therapy in children undergoing cardiac surgery.",[26,27],"Heart; Dysfunction Postoperative, Cardiac Surgery","C.Surgical Procedure; Cardiac",[29,30,31],"lactate","central venous saturation","Pediatric Cardiac Surgery","RECRUITING","2024-08-21",{"date":35,"type":36},"2024-08-23","ACTUAL",{"date":38,"type":36},"2018-02-01",{"date":40,"type":20},"2024-12",{"name":42,"class":43},"Instituto do Coracao","OTHER_GOV",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":4,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":72},"100152594","identification-of-genomic-predictors-of-adverse-events-after-cardiac-surgery-100152594","NCT01258231","Identification of Genomic Predictors of Adverse Events After Cardiac Surgery","CABGGenomics","Inclusion Criteria:\n\n* Undergoing heart surgery\n* Willing to provide consent\n\nExclusion Criteria:\n\n* Enrolled in a concurrent drug or device trial that precludes concurrent enrollment","20 Years","90 Years",{"count":55,"type":20},4000,"OBSERVATIONAL","This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.\n\nPatients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.",[26,59,60,61,62],"Genetic Predisposition to Disease","Atrial Fibrillation","Myocardial Infarction","Heart Failure",{"date":64,"type":36},"2024-08-22",{"date":66,"type":36},"2000-08",{"date":68,"type":20},"2030-08",{"name":70,"class":71},"Brigham and Women's Hospital","OTHER",3]